Researchers Database
SAKURAI SHINTAROU
Affiliation： Department of Endocrinology and Metabolism | |||
Last Updated :2025/04/28
Research achievements
Published Papers
- 8(2), 445-449, Apr. 2017
- 47(1), 52-60, 2012
- Empagliflozin decreases the plasma concentration of plasminogen activator inhibitor-1 (PAI-1) in patients with type 2 diabetes: Association with improvement of fibrinolysis., Sakurai Shintaro;Jojima Teruo;Iijima Toshie;Tomaru Takuya;Usui Isao;Aso Yoshimasa, Journal of diabetes and its complications, 34(11), 107703, 2020
- Teneligliptin, a DPP-4 Inhibitor, Decreases Plasma Levels of Inflammatory Chemokines During a Standard Meal Test in Patients With Type 2 Diabetes., Aso Yoshimasa;Kase Masato;Sagara Masaaki;Sakurai Shintaro;Iijima Toshie;Tomaru Takuya;Jojima Teruo;Usui Isao, The American journal of the medical sciences, 360(3), 261-267, 2020
- Acute effect of add-on therapy with tofogliflozin, a sodium glucose co-transporter 2 inhibitor, on 24-hours glucose profile and glycaemic variability evaluated by continuous glucose monitoring in patients with type 2 diabetes receiving dipeptidyl peptidase-4 inhibitors., Iijima Toshie;Hosonuma Soichiro;Kurai Hidetaka;Kajitani Hayato;Sakurai Shintaro;Tomaru Takuya;Jojima Teruo;Usui Isao;Aso Yoshimasa, International journal of clinical practice, 75(11), e14732, 19 Aug. 2021
- Serum levels of soluble dipeptidyl peptidase-4 in type 2 diabetes are associated with severity of liver fibrosis evaluated by transient elastography (FibroScan) and the FAST (FibroScan-AST) score, a novel index of non-alcoholic steatohepatitis with significant fibrosis., Sagara Masaaki;Iijima Toshie;Kase Masato;Kato Kanako;Sakurai Shintaro;Tomaru Takuya;Jojima Teruo;Usui Isao;Aso Yoshimasa, Journal of diabetes and its complications, 35(5), 107885, 06 Feb. 2021
- Empagliflozin increases plasma levels of campesterol, a marker of cholesterol absorption, in patients with type 2 diabetes: Association with a slight increase in high-density lipoprotein cholesterol., Jojima Teruo;Sakurai Shintaro;Wakamatsu Sho;Iijima Toshie;Saito Masahiro;Tomaru Takuya;Kogai Takahiko;Usui Isao;Aso Yoshimasa, International journal of cardiology, 331, 243-248, 05 Feb. 2021
- Increased Number of Mucosal-Associated Invariant T Cells Is Associated with the Inhibition of Nonalcoholic Fatty Liver Disease in High Fat Diet-Fed Mice., Kishi Haruka;Usui Isao;Jojima Teruo;Fujisaka Shiho;Wakamatsu Sho;Mizunuma-Inoue Yuiko;Niitani Takafumi;Sakurai Shintaro;Iijima Toshie;Tomaru Takuya;Tobe Kazuyuki;Aso Yoshimasa, International journal of molecular sciences, 23(23), 04 Dec. 2022
- Effects of treatment with methimazole on circulating CD4+ and CD8+ T cells positive for programed cell death protein-1 and on subsets of CD4+ T cells in untreated hyperthyroid patients with Graves' disease., Hirao Nanako;Iijima Toshie;Tanuma Dai;Ohira Eriko;Kurai Hidetaka;Shinzawa Toshimitsu;Kase Masato;Sakurai Shintaro;Tomaru Takuya;Jojima Teruo;Usui Isao;Aso Yoshimasa, Clinical endocrinology, 97(6), 841-848, 17 Jun. 2022
- Synergistic effects of liver fibrosis and sarcopenia on endothelial dysfunction and arterial stiffness in patients with type 2 diabetes., Jojima Teruo;Kurai Hidetaka;Tanuma Dai;Kajitani Hayato;Kase Masato;Inoue Yuiko;Sakurai Shintaro;Iijima Toshie;Tomaru Takuya;Usui Isao;Aso Yoshimasa, International journal of cardiology. Heart & vasculature, 41, 101071, 16 Jun. 2022
- Switching from the tablet to the powder formulation of levothyroxine corrects severe hypothyroidism in a patient with lactose intolerance., Jojima Teruo;Shinzawa Toshimitsu;Ohira Eriko;Sakurai Shintaro;Tomaru Takuya;Iijima Toshie;Kogai Takahiko;Usui Isao;Aso Yoshimasa, Endocrine journal, 69(8), 941-945, 04 Mar. 2022
- Acute Exacerbation of Anemia with Parvovirus B19 Infection One Year after Sleeve Gastrectomy for Severe Obesity., Shinzawa Toshimitsu;Usui Isao;Hanawa Kanako;Kajitani Hayato;Sakurai Shintaro;Tomaru Takuya;Iijima Toshie;Jojima Teruo;Kojima Kazuyuki;Aso Yoshimasa, Internal medicine (Tokyo, Japan), 61(17), 2631-2635, 08 Feb. 2022
- Inhibition of IL-33 signaling ameliorate hepatic fibrosis with decreasing MCP-1 in a mouse model of diabetes and non-alcoholic steatohepatitis; comparison for luseogliflozin, an SGLT2 inhibitor., Wakamatsu Sho;Jojima Teruo;Hashiguchi Masaaki;Kishi Haruka;Niitani Takafumi;Sakurai Shintaro;Iijima Toshie;Kogai Takahiko;Tomaru Takuya;Usui Isao;Aso Yoshimasa, Journal of diabetes and its complications, 38(1), 108650, 23 Nov. 2023
Original paper
- Genetic alteration of ARMC5 in a patient diagnosed with meningioma and primary macronodular adrenal hyperplasia: a case report., Jojima Teruo;Kogai Takahiko;Iijima Toshie;Kato Kanako;Sagara Masaaki;Kezuka Atsumi;Kase Masato;Sakurai Shintaro;Akimoto Kazumi;Sakumoto Junko;Namatame Takashi;Ueki Keisuke;Hishinuma Akira;Kamai Takao;Usui Isao;Aso Yoshimasa, European journal of endocrinology, 183(6), K7-K12, Dec. 2020
- Bullous pemphigoid associated with dipeptidyl peptidase-4 inhibitor showing unfavorable outcomes despite immediate discontinuation of medication., Shinohara Yasutake;Iijima Toshie;Sakurai Shintaro;Jojima Teruo;Ohira Eriko;Hayashi Shujiro;Usui Isao;Igawa Ken;Aso Yoshimasa, Clinical case reports, 8(10), 2007-2012, Oct. 2020
Case report
- Relationship between reduced heart rate variability and increased arterial stiffness evaluated by the cardio-ankle vascular index in people with type 2 diabetes., Kase Masato;Iijima Toshie;Niitani Takafumi;Sagara Masaaki;Sakurai Shintaro;Tomaru Takuya;Jojima Teruo;Usui Isao;Aso Yoshimasa, Diabetology international, 14(1), 94-102, 29 Sep. 2022
Unclear